Insights

High-impact AI proteins Target biotech and industrial manufacturers seeking novel proteins for metal refinement, plastic recycling, and carbon capture. Aether’s AI-driven protein discovery and proprietary screening platform could shorten development timelines for clients needing specialized enzymes and materials.

Commercialization momentum Leverage existing traction in translating AI breakthroughs into ready-to-market high-performance materials capable of rapid production and enhanced strength. Market to defense, aerospace, and manufacturing sectors prioritizing faster, stronger outputs and cost efficiencies.

Sustainability positioning Position offerings around environmental impact: breaking down persistent chemicals, recycling plastics, and reducing carbon footprints. Align with ESG-focused procurement in industrials, chemicals, and government programs prioritizing green tech adoption.

Strategic partnerships Explore collaborations with manufacturing innovators, materials suppliers, and environmental remediation firms that need advanced proteins or AI-enabled discovery pipelines. Joint ventures could accelerate scale and widen application footprints.

Financial readiness With sizable funding and revenue in a growth phase, present scalable solutions and licensing or co-development models to potential customers seeking low-risk, high-reward AI biotech integrations. Emphasize proven platform capabilities and diverse class of proteins.

Similar companies to Aether

Aether Tech Stack

Aether uses 8 technology products and services including Canva, Amazon Web Services, Jenkins, and more. Explore Aether's tech stack below.

Media & News

Aether's Email Address Formats

Aether uses at least 2 email formats:
Aether Email FormatsExamplePercentage
First@aetherbio.comJohn@aetherbio.com
87%
FLast@aetherbio.comJDoe@aetherbio.com
13%

Frequently Asked Questions

What is Aether's stock symbol?

Minus sign iconPlus sign icon
Aether is a publicly traded company; the company's stock symbol is GMFIU.

What is Aether's official website and social media links?

Minus sign iconPlus sign icon
Aether's official website is aetherbio.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Aether generate?

Minus sign iconPlus sign icon
As of August 2026, Aether's annual revenue is estimated to be $10M - $25M.

What is Aether's SIC code and NAICS code?

Minus sign iconPlus sign icon
Aether's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Aether have currently?

Minus sign iconPlus sign icon
As of August 2026, Aether has approximately 94 employees across 6 continents, including North America, Europe and Asia. Key team members include Head Of Catalytic Reactor Engineering: A. R., Head Of Business Development, Materials: G. C. and Founder: Z. S. W. Explore Aether's employee directory with LeadIQ.

What industry does Aether belong to?

Minus sign iconPlus sign icon
Aether operates in the Biotechnology Research industry.

What technology does Aether use?

Minus sign iconPlus sign icon
Aether's tech stack includes Canva, Amazon Web Services, Jenkins, PostgreSQL, Figma, Amazon Simple Email Service, Google Workspace and Webflow.

What is Aether's email format?

Minus sign iconPlus sign icon
Aether's email format typically follows the pattern of First@aetherbio.com. Find more Aether email formats with LeadIQ.

How much funding has Aether raised to date?

Minus sign iconPlus sign icon
As of August 2026, Aether has raised $64M in funding. The last funding round occurred on Oct 22, 2025 for $320K.

When was Aether founded?

Minus sign iconPlus sign icon
Aether was founded in 2017.
Aether logo

Aether

Biotechnology ResearchCalifornia, United States51-200 Employees

Aether Biomachines, Inc. operates at the intersection of biotechnology research and artificial intelligence, focusing on discovering proteins with practical, real-world applications. Its work centers on a Protein Function Model supported by an in-house proprietary dataset developed through high-throughput screening and innovative assay techniques. The company reports seven new protein classes that enable functions including refining metals at lower cost, breaking down persistent pollutants, producing advanced materials, supporting pharmaceutical manufacturing, recycling plastics, and capturing carbon dioxide, with materials claimed to print ten times faster than current benchmarks and to offer enhanced strength for defense and aerospace.

Headquartered in Menlo Park, California, the firm positions itself in the biotechnology research sector by leveraging AI-designed proteins to address industrial-scale challenges. In late 2025, it introduced RapidPrint, a polymer filament product for high-performance 3D printing, reflecting a concrete product development.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
GMFIU
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2017
Employees
51-200

Section iconFunding & Financials

  • $64M

    Aether has raised a total of $64M of funding over 12 rounds. Their latest funding round was raised on Oct 22, 2025 in the amount of $320K as a Venture Round.

  • $10M - $25M

    Aether's revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.